Basics Humacyte, Inc. Common Stock IPO Date: November 30, 2020 Sector: Healthcare Industry: Biotech Market Cap: $226.47M Activated in VL: True Average Daily Range Avg Daily Range: $0.18 | 3.84% Avg Daily Range (30 D): $0.06 | 3.19% Avg Daily Range (90 D): $0.07 | 3.52% Institutional Daily Volume Avg Daily Volume: 1.47M Avg Daily Volume (30 D): 4.62M Avg Daily Volume (90 D): 4.03M Trade Size Avg Trade Size (Sh.): 170 Avg Trade Size (Sh.) (30 D): 317 Avg Trade Size (Sh.) (90 D): 284 Institutional Trades Total Inst.Trades: 298 Avg Inst. Trade: $1.44M Avg Inst. Trade (30 D): $1.18M Avg Inst. Trade (90 D): $1.54M Avg Inst. Trade Volume: .31M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.55M Avg Closing Trade (30 D): $.68M Avg Closing Trade (90 D): $1.99M Avg Closing Volume: 315.39K     News Aug 11, 2025 @ 11:20 AM Humacyte Posts Q2 Revenue Miss Source: Jesterai Mar 26, 2025 @ 10:18 AM US Stocks Likely To Open Lower After 3-Day Advance... Source: Rishabh Mishra Jan 21, 2025 @ 3:44 PM DEADLINE ALERT for WOLF, HUMA, XRX, and ZETA: The ... Source: The Law Offices Of Frank R. Cruz Jan 17, 2025 @ 5:28 PM HUMA Investors Have Opportunity to Lead Humacyte, ... Source: Business Wire Jan 17, 2025 @ 3:47 PM HUMA DEADLINE TODAY: ROSEN, A TOP RANKED LAW FIRM,... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.24 $.28 $-.16 Diluted EPS $-.24 $.28 $-.16 Revenue $ .3M $ .52M $ M Gross Profit $ .09M $ .37M $ Net Income / Loss $ -37.66M $ 39.14M $ -20.94M Operating Income / Loss $ -29.73M $ -23.18M $ -28.09M Cost of Revenue $ .21M $ .15M $ Net Cash Flow $ -24.82M $ 17.91M $ 24.37M PE Ratio